|
Young Smoker's Reactions to Genetic Risk for Lung Cancer
|
5R01CA121922-05
|
$192,611
|
LIPKUS, ISAAC
|
DUKE UNIVERSITY
|
|
Walking Forward - American Indian Participation in Cancer Clinical Trials
|
3U54CA142157-03S1
|
$139,968
|
PETEREIT, DANIEL
|
RAPID CITY REGIONAL HOSPITAL
|
|
Walking Forward - American Indian Participation in Cancer Clinical Trials
|
5U54CA142157-03
|
$932,394
|
PETEREIT, DANIEL
|
RAPID CITY REGIONAL HOSPITAL
|
|
Vitamin D and Colorectal Cancer
|
5R01CA122299-04
|
$335,470
|
BENYA, RICHARD
|
UNIVERSITY OF ILLINOIS AT CHICAGO
|
|
Validation of Genomic Targets in Melanoma
|
2R01CA114337-07A1
|
$370,543
|
KASHANI-SABET, MOHAMMED
|
CALIFORNIA PACIFIC MED CTR RES INSTITUTE
|
|
Validation of copy number changes by MLPA as predictors of relapse in Wilms tumor
|
1R21CA155556-01
|
$191,835
|
PERLMAN, ELIZABETH
|
CHILDREN'S MEMORIAL HOSPITAL (CHICAGO)
|
|
Validation and extension of the PREMM Model for mismatch repair gene mutations
|
5R01CA132829-04
|
$379,100
|
SYNGAL, SAPNA
|
DANA-FARBER CANCER INSTITUTE
|
|
UT M.D. Anderson Cancer Center
|
5U10CA045809-23
|
$2,179,856
|
FISCH, MICHAEL
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
USC Norris Comprehensive Cancer Center (CORE) Support
|
2P30CA014089-36
|
$6,160,984
|
JONES, PETER
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC Norris Comprehensive Cancer Center (CORE) Support
|
3P30CA014089-36S1
|
$50,000
|
JONES, PETER
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC Norris Comprehensive Cancer Center (CORE) Support
|
3P30CA014089-36S2
|
$244,500
|
JONES, PETER
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC Norris Comprehensive Cancer Center (CORE) Support
|
3P30CA014089-36S3
|
$74,923
|
JONES, PETER
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
University of Texas M.D. Anderson Cancer Center SPORE - Leukemia
|
5P50CA100632-09
|
$2,185,000
|
Kantarjian, Hagop
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
University of New Mexico Cancer Center Support
|
3P30CA118100-07S1
|
$49,474
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO
|
|
University of New Mexico Cancer Center Support
|
3P30CA118100-07S2
|
$75,000
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO
|
|
University of New Mexico Cancer Center Support
|
3P30CA118100-07S3
|
$140,000
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO
|
|
University of New Mexico Cancer Center Support
|
5P30CA118100-07
|
$1,934,104
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-23S2
|
$50,000
|
WICHA, MAX
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-23S3
|
$5,694,947
|
WICHA, MAX
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
Transponson-based screens for genes involved in acute lymphoblastic Leukemia
|
1R01CA154998-01A1
|
$308,891
|
Farrar, Michael
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
|
Translational Medicine and Cancer Therapy with Vasculature-Targeted Agents
|
5K23CA124802-05
|
$129,843
|
Maitland, Michael
|
UNIVERSITY OF CHICAGO
|
|
Transformation by the NEU Oncogene Product and EGF
|
5R01CA045708-23
|
$336,647
|
STERN, DAVID
|
YALE UNIVERSITY
|
|
Transdisciplinary Studies of Genetic Variation in Colorectal Cancer
|
5U19CA148107-02
|
$2,603,669
|
GRUBER, STEPHEN
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
Transdisciplinary Research in Cancer of the Lung (TRICL)
|
5U19CA148127-02
|
$2,612,327
|
AMOS, CHRISTOPHER
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Toward a molecular classification of human gliomas
|
5R01CA057683-18
|
$301,819
|
LOUIS, DAVID
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Tools for detecting biologically important sequence variation in cancer
|
1R21CA152432-01A1
|
$269,680
|
KARCHIN, RACHEL
|
JOHNS HOPKINS UNIVERSITY
|
|
The Role of Caspase-8 in Neuroblastoma Tumorigenesis
|
5R01CA067938-13
|
$383,429
|
LAHTI, JILL
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
The Role of Behavioral Science in Personalized Genetic Medicine
|
5K07CA131172-04
|
$136,770
|
GRAVES, KRISTI
|
GEORGETOWN UNIVERSITY
|
|
The Role of Aberrant Splicing of EVl1 in Ovarian Cancer Pathophysiology
|
5R01CA123219-04
|
$305,140
|
MILLS, GORDON
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-18S1
|
$72,130
|
Rosen, Steven
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-18S2
|
$75,000
|
Rosen, Steven
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
5P30CA060553-18
|
$4,829,858
|
Rosen, Steven
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
The pVHL/Jade-1/beta-catenin axis in renal cancer
|
5R01CA079830-10
|
$320,196
|
COHEN, HERBERT
|
BOSTON MEDICAL CENTER
|
|
THE PATHOGENESIS OF DYSKERATOSIS CONGENITA
|
5R01CA106995-07
|
$313,388
|
MASON, PHILIP
|
CHILDRENS HOSPITAL OF PHILADELPHIA
|
|
The Pacific Northwest Prostate Cancer SPORE
|
5P50CA097186-10
|
$2,185,000
|
NELSON, PETER
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
The NIH Pediatric and wildtype GIST Clinic
|
ZIA BC 011196
|
$152,510
|
Kim, Su Young
|
CCR (NCI)
|
|
The Molecular Basis for Bortezomib Activity
|
5R01CA129009-05
|
$295,041
|
STEWART, ALEXANDER
|
MAYO CLINIC ARIZONA
|
|
The Genetics and Prevention of Gastrointestinal Cancers
|
5K24CA113433-07
|
$196,416
|
SYNGAL, SAPNA
|
DANA-FARBER CANCER INSTITUTE
|
|
The Genetic Basis of Neuroblastoma Tumorigenesis
|
5R01CA124709-04
|
$625,023
|
MARIS, JOHN
|
CHILDRENS HOSPITAL OF PHILADELPHIA
|
|
The Colon Cancer Family Registry: USC Consortium
|
5U24CA074799-13
|
$1,740,161
|
HAILE, ROBERT
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
The Colon Cancer Family Registry: Hawaii
|
5U24CA074806-13
|
$425,502
|
LE MARCHAND, LOIC
|
UNIVERSITY OF HAWAII AT MANOA
|
|
The Colon Cancer Family Registry: Australasia
|
5U24CA097735-09
|
$1,510,087
|
HOPPER, JOHN
|
UNIVERSITY OF MELBOURNE
|
|
Telomeres and lung cancer incidence and survival
|
1R01CA151989-01A1
|
$725,296
|
Doherty, Jennifer
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Telomere dysfunction, chromosome 9 instability and bladder cancer risk
|
5R01CA132996-03
|
$588,169
|
ZHENG, YUN-LING
|
GEORGETOWN UNIVERSITY
|
|
Taxane Resistance in Breast and Ovarian Cancer Cells
|
5R01CA114037-05
|
$288,798
|
SIKIC, BRANIMIR
|
STANFORD UNIVERSITY
|
|
TAS::75 0849::TAS SBIR TOPIC 277 - DEVELOPMENT OF A CLINICAL DIAGNOSTIC ASSAY FOR
|
N43CO110110-000
|
$193,637
|
HOUT, DAVID
|
INSIGHT GENETICS, INC.
|
|
Targeting Oncogenic ALK Signaling in Neuroblastoma
|
5R01CA140198-03
|
$331,098
|
Mosse, YAEL
|
CHILDRENS HOSPITAL OF PHILADELPHIA
|
|
Surveillance, Epidemiology, and End Results (SEER) Program
|
N01PC190030-005
|
$1,669,594
|
CHEN, VIVIEN
|
LOUISIANA STATE UNIVERSITY SYSTEM
|
|
Surveillance, Epidemiology, and End Results (SEER) Program
|
N01PC100027-004
|
$1,101,980
|
GRAFF, JOHN J.
|
UMDNJ-ROBERT WOOD JOHNSON MEDICAL SCHOOL
|
|
Surveillance, Epidemiology and End Results Program
|
N01PC100034-004
|
$2,577,965
|
WEST, DEE
|
PUBLIC HEALTH INSTITUTE
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|